Sintesi e caratterizzazione strutturale di derivati piperidinici e morfolinici chirali

The topic of this thesis concerns the study of catalytic processes for the synthesis of chiral 3,4,5-trisubstituted piperidine and 2,6-disubstituted morpholine. Substrates possessing an α,β-unsaturated ester and a ketone moiety, able to undergo addition/cyclization cascade reactions with different pro-nucleophiles (thiophenols, acetone cyanohydrin and malononitrile), have been evaluated. Chiral and achiral systems for phase-transfer catalysis have been applied as catalysts. Moderate enantiomeric excesses have been obtained for the morpholinic products and good to excellent values for the piperidinic products, by using cyclopeptoids and quaternary ammonium salts derived from Chincona alkaloids as catalysts respectively. Moreover, the absolute configuration of the 3,4,5-trisubstituted piperidines has been determined through quantomechanical simulations of their chirooptical spectra. Finally, the relative configuration of the 2,6-disubstituted morpholines has been assigned through NMR experiments.

Development of advanced analytical methodologies for Alzheimer’s disease drug discovery

Advanced analytical methodologies were developed to characterize new potential active MTDLs on isolated targets involved in the first stages of Alzheimer’s disease (AD). In addition, the methods investigated drug-protein bindings and evaluated protein-protein interactions involved in the neurodegeneration. A high-throughput luminescent assay allowed the study of the first in class GSK-3β/ HDAC dual inhibitors towards the enzyme GSK-3β. The method was able to identify an innovative disease-modifying agent with an activity in the micromolar range both on GSK-3β, HDAC1 and HDAC6. Then, the same assay reliably and quickly selected true positive hit compounds among natural Amaryllidaceae alkaloids tested against GSK-3β. Hence, given the central role of the amyloid pathway in the multifactorial nature of AD, a multi-methodological approach based on mass spectrometry (MS), circular dichroism spectroscopy (CD) and ThT assay was applied to characterize the potential interaction of CO releasing molecules (CORMs) with Aβ1-42 peptide. The comprehensive method provided reliable information on the different steps of the fibrillation process and regarding CORMs mechanism of action. Therefore, the optimal CORM-3/Aβ1−42 ratio in terms of inhibitory effect was identified by mass spectrometry. CD analysis confirmed the stabilizing effect of CORM-3 on the Aβ1−42 peptide soluble form and the ThT Fluorescent Analysis ensured that the entire fibrillation process was delayed. Then the amyloid aggregation process was studied in view of a possible correlation with AD lipid brain alterations. Therefore, SH-SY5Y cells were treated with increasing concentration of Aß1-42 at different times and the samples were analysed by a RP-UHPLC system coupled with a high-resolution quadrupole TOF mass spectrometer in comprehensive data-independent SWATH acquisition mode. Each lipid class profiling in SH-SY5Y cells treated with Aß1-42 was compared to the one obtained from the untreated. The approach underlined some peculiar lipid alterations, suitable as biomarkers, that might be correlated to Aß1-42 different aggregation species.